Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Innate Pharma S.A. - American Depositary Shares
(NQ:
IPHA
)
1.970
+0.070 (+3.68%)
Streaming Delayed Price
Updated: 10:39 AM EST, Dec 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Innate Pharma S.A. - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025
November 28, 2025
From
Innate Pharma SA
Via
Business Wire
Innate Pharma to Present at Jefferies Global Healthcare Conference
November 17, 2025
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results
November 13, 2025
From
Innate Pharma SA
Via
Business Wire
Get insights into the top gainers and losers of Tuesday's pre-market session.
↗
November 11, 2025
Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.
Via
Chartmill
IPHA Stock Soars Pre-Market After FDA Clears Late-Stage Trial For Lacutamab In Rare Skin Cancers
↗
November 10, 2025
Via
Stocktwits
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
November 11, 2025
Via
Benzinga
Why Rocket Lab Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
↗
November 11, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
November 10, 2025
Via
Benzinga
Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL
November 10, 2025
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates
November 05, 2025
From
Innate Pharma SA
Via
Business Wire
This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
↗
October 29, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 14, 2025
Via
Benzinga
Innate Pharma to Host Analyst and Investor Event on Lacutamab on October 28, 2025
October 14, 2025
From
Innate Pharma SA
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
September 30, 2025
Via
Benzinga
This Progressive Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
↗
September 18, 2025
Via
Benzinga
Alphabet To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Thursday
↗
September 18, 2025
Via
Benzinga
Earnings Scheduled For September 17, 2025
↗
September 17, 2025
Via
Benzinga
Innate Pharma Reports First Half 2025 Business Update and Financial Results
September 17, 2025
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Announces Its Participation in the 25th Edition of the European Midcap Event
September 15, 2025
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update
September 10, 2025
From
Innate Pharma SA
Via
Business Wire
Number of Shares and Voting Rights of Innate Pharma as of September 1, 2025
September 02, 2025
From
Innate Pharma SA
Via
Business Wire
Number of Shares and Voting Rights of Innate Pharma as of August 1, 2025
August 04, 2025
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Announces Its Participation in the BTIG Virtual Biotechnology Conference
July 29, 2025
From
Innate Pharma SA
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
July 28, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
July 18, 2025
Via
Benzinga
Number of Shares and Voting Rights of Innate Pharma as of July 3, 2025
July 04, 2025
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences
June 17, 2025
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Highlights Preclinical Antitumor Activity of IPH6501 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma at the 2025 European Hematology Association (EHA) Congress
June 13, 2025
From
Innate Pharma SA
Via
Business Wire
Innate Pharma Announces Its Participation in Jefferies and Goldman Sachs Healthcare Conferences
May 27, 2025
From
Innate Pharma SA
Via
Business Wire
Outcome of Innate Pharma’s 2025 Annual General Meeting
May 23, 2025
From
Innate Pharma SA
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
